Search

everythinglearnresearchcommunity

for

Search:↓

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Scalp psoriasis is a chronic condition that can be managed with treatments like corticosteroids and salicylic acid.

The study developed a successful mouse model to study skin infections, highlighting the importance of choosing the right fungal strains.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Epiduo® is an effective first-line acne treatment that reduces inflammation and combats antibiotic resistance.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Janus kinase inhibitors show promise for treating alopecia areata in children.

Dupilumab users have a higher risk of developing alopecia areata.

Dupilumab may worsen hair loss in patients with alopecia areata.

Dupilumab may cause hair loss, so patients should be monitored.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Ulcerative colitis can cause skin issues due to immune system problems.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

IL-18 signaling helps mature Tregs move into the thymus.